Knowledge hub

Human antibody reaction against recombinant salivary proteins of Phlebotomus orientalis in Eastern Africa

Study that aimed at uncovering valid markers of human exposure to vector sanfly P. orientalis order to help monitor the distribution of the VL vector and shape anti-vector interventions. The researchers "screened for anti-P. orientalis antibody responses in serum samples from individuals residing in Sudan and Ethiopia".

27 Dec 2019
Academic paper
Improving surveillance
Sudan, Ethiopia

Treatment outcomes of visceral leishmaniasis in Ethiopia from 2001 to 2017: a systematic review and meta-analysis

A systematic review of 15 studies examining VL treatment outcomes at end of treatment and at 6 months follow-up in Ethiopia.

25 Mar 2019
Academic paper
Case management
Ethiopia

Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens

Review of the current diagnostic and treatment tools used for the management of visceral leishmaniasis.

8 Mar 2019
Academic paper
Case management

Eliminating visceral leishmaniasis in South Asia: the road ahead

This paper reviews recent progress for VL control measures and identifies priority areas to reach the 2020 VL elimination target in the South Asian region.

5 Mar 2019
Academic paper
India, Bangladesh, Nepal

National Strategic Guideline on Kala-azar Elimination Program in Nepal 2014

The revised National Guideline for Kala azar elimination by the Epidemiology and Disease Control Division (EDCD) of the Ministry of Health and Population, Government of Nepal. For more information on the National program, see http://www.edcd.gov.np/section/kala-azar-elimination-program .

1 Mar 2019
Policy paper

National Strategic Guideline on Kala-azar Elimination Program in Nepal 2014

The revised National Guideline for Kala azar elimination by the Epidemiology and Disease Control Division (EDCD) of the Ministry of Health and Population, Government of Nepal. For more information on the National program, see http://www.edcd.gov.np/section/kala-azar-elimination-program .

1 Mar 2019
Policy paper
Nepal

National Strategic Guideline on Kala-azar Elimination Program, Nepal (2014)

The revised National Guideline for Kala azar elimination by the Epidemiology and Disease Control Division (EDCD) of the Ministry of Health and Population, Government of Nepal. For more information on the National program, see http://www.edcd.gov.np/section/kala-azar-elimination-program .

1 Mar 2019
Policy paper
Nepal

National Strategic Guideline on Kala-azar Elimination Program (Nepal, 2014)

The revised National Guideline for Kala azar elimination by the Epidemiology and Disease Control Division (EDCD) of the Ministry of Health and Population, Government of Nepal. For more information on the National program, see http://www.edcd.gov.np/section/kala-azar-elimination-program .

1 Mar 2019
Policy paper
Nepal

Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL‐program districts with non‐program districts

A cross‐sectional mixed‐method study on populations from districts targeted by the national VL programme and non‐program districts. The researchers describe delays to health-seeking, to diagnosis and to treatment in the two populations and identify barriers to access in Nepal.

13 Feb 2019
Academic paper
Improving surveillance
Nepal

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia

This study reports on the results of a randomized trial of AmBisome - miltefosine combination therapy and AmBisome monotherapy in Ethiopian HIV-VL co-patients, in order to assess dose efficacy at the end of treatment.
 
The authors conclude that "the extended treatment strategy with the combination regimen showed the highest documented efficacy in HIV-VL patients; these results support a recommendation of this regimen as first-line treatment strategy for HIV-VL patients in eastern Africa".
31 Jan 2019
Academic paper
Case management
Ethiopia

Pages